Results 81 to 90 of about 11,617 (181)
Anti-platelet factor 4 (PF4) disorders are a group of platelet-consumptive disorders characterized by platelet-activating antibodies against PF4, thrombocytopenia and an increased risk of thrombosis.
Bianca Clerici +2 more
doaj +1 more source
This paper expands a systems‑level regenerative immunology framework by introducing Platelet Factor 4 (PF4) as a mechanistic co‑signal for immune‑guided tissue repair. Building on prior work in TH17 plasticity and TH22 stabilization, the paper explores how PF4’s hematopoietic and anti‑inflammatory properties can reinforce long‑term immune recalibration.
openaire +1 more source
Anti‐
SummaryPlatelet factor 4 (PF4) is a cationic protein, able to form complexes with negatively charged molecules upon its self‐assembly into PF4 tetramers. The targeting of these PF4 complexes by immunoglobulin G (IgG) antibodies underlies anti‐PF4 disorders such as heparin‐induced thrombocytopenia (HIT) and Vaccine‐Induced Immune Thrombocytopenia and ...
Megan V. Preece +3 more
openaire +2 more sources
Anti-platelet factor 4 (PF4) immunothrombosis is characterized by thrombocytopenia, thrombosis and enhanced NETosis and has been described in the absence of prior heparin exposure.
Lital Remez-Gabay +8 more
doaj +1 more source
Antiphospholipid and anti‐PF4 antibodies: an association affecting anti‐PF4/heparin assay analysis [PDF]
openaire +2 more sources
The hidden threat: understanding anti-PF4 disorders without proximate heparin exposure. [PDF]
Liu Z, Li Y, Ma L, Wang X, Cui Y.
europepmc +1 more source
Induction of the filamentous prophage, Pf4, is conditionally regulated by PA3572 (<i>difP</i>) in <i>Pseudomonas aeruginosa</i> biofilms. [PDF]
Patell SZ, Welch M.
europepmc +1 more source

